Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Neurology and Therapy
|
February 22, 2023
Pridopidine Does Not Significantly Prolong the QTc Interval at the Clinically Relevant Therapeutic Dose
Borje Darpo, Michal Geva, Georg Ferber, et al.
Pain
|
January 18, 2014
Letter to the editor
Yigal Paul Goldberg, Charles J Cohen, Rostam Namdari, et al.
Journal of Human Genetics
|
October 16, 2015
BMPER variants associated with a novel, attenuated subtype of diaphanospondylodysostosis
Zheyuan Zong, Susan Tees, Firoz Miyanji, et al.
Pain
|
November 1, 2011
Treatment of Na(v)1.7-mediated pain in inherited erythromelalgia using a novel sodium channel blocker
Yigal Paul Goldberg, Nicola Price, Rostam Namdari, et al.
CNS Drugs
|
March 7, 2025
The Safety Profile of Pridopidine, a Novel Sigma-1 Receptor Agonist for the Treatment of Huntington's Disease
Yigal Paul Goldberg, Leehee Navon-Perry, Andrés Cruz-Herranz, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Neurology and Therapy
|
February 22, 2023
Pridopidine Does Not Significantly Prolong the QTc Interval at the Clinically Relevant Therapeutic Dose
Borje Darpo, Michal Geva, Georg Ferber, et al.
Pain
|
January 18, 2014
Letter to the editor
Yigal Paul Goldberg, Charles J Cohen, Rostam Namdari, et al.
Journal of Human Genetics
|
October 16, 2015
BMPER variants associated with a novel, attenuated subtype of diaphanospondylodysostosis
Zheyuan Zong, Susan Tees, Firoz Miyanji, et al.
Pain
|
November 1, 2011
Treatment of Na(v)1.7-mediated pain in inherited erythromelalgia using a novel sodium channel blocker
Yigal Paul Goldberg, Nicola Price, Rostam Namdari, et al.
CNS Drugs
|
March 7, 2025
The Safety Profile of Pridopidine, a Novel Sigma-1 Receptor Agonist for the Treatment of Huntington's Disease
Yigal Paul Goldberg, Leehee Navon-Perry, Andrés Cruz-Herranz, et al.
Page
of 1